Company facts
- Industry
- Services-Medical Laboratories
- Headquarters
- South San Francisco, California
- Most recent report
- 8-K, filed Sep 14, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1384101
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 48
News 8 of 124
Prospectuses and Registrations 8 of 48
- S-8 Registration statement for an employee plan Jun 10, 2026
- S-8 Registration statement for an employee plan Jun 17, 2025
- S-8 Registration statement for an employee plan Jun 12, 2024
- S-8 Registration statement for an employee plan Feb 29, 2024
- S-3ASR Automatic shelf registration Feb 29, 2024
- S-8 POS Post-effective amendment to an employee plan registration Jun 8, 2023
- S-8 POS Post-effective amendment to an employee plan registration Jun 8, 2023
- S-8 POS Post-effective amendment to an employee plan registration Jun 8, 2023
Proxies 8 of 24
- DEFA14A Extra proxy material Apr 22, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- DEFA14A Extra proxy material Apr 25, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2024
- DEFA14A Extra proxy material Jun 1, 2023
- DEFA14A Extra proxy material Apr 27, 2023
Ownership 8 of 714
- 144 Notice of a proposed sale of restricted stock Sep 24, 2026
- 4 Insider reported a trade Sep 22, 2026
- 144 Notice of a proposed sale of restricted stock Sep 21, 2026
- 4 Insider reported a trade Sep 16, 2026
- 144 Notice of a proposed sale of restricted stock Sep 14, 2026
- 4 Insider reported a trade Sep 4, 2026
- 4 Insider reported a trade Sep 4, 2026
- 4 Insider reported a trade Sep 4, 2026
Other 8 of 42
- ARS Annual report sent to shareholders Apr 22, 2026
- ARS Annual report sent to shareholders Apr 29, 2025
- UPLOAD Comment letter from SEC staff Jun 13, 2024
- CORRESP Reply to SEC staff Jun 7, 2024
- UPLOAD Comment letter from SEC staff May 28, 2024
- ARS Annual report sent to shareholders Apr 25, 2024
- 424B7 Mar 22, 2024
- 424B7 Feb 29, 2024
Everything here comes from Veracyte, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.